Clinical Trials Arena August 23, 2024
Robert Barrie

Microbot’s Liberty system is also being evaluated in an IDE study as the company aims to join the billion-dollar surgical robotics market.

Microbot has expanded a collaboration with Corewell Health to evaluate its Liberty endovascular robotic system in remote telesurgery applications.

The agreement, which has advanced into a second phase, will see simulated cardiovascular interventional procedure capabilities developed across two sites within the Corewell Health system.

The agreement with Corewell Health, which is Michigan’s largest healthcare system, includes the right to mutually evaluate the Liberty system.

US-based Microbot’s Liberty system is a single-use endovascular surgical robot designed to remove the need for large and expensive capital equipment. The technology is being evaluated in the LIBERTY study under an investigational device...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry

Share This Article